Recent

% | $
Quotes you view appear here for quick access.

Linktone Ltd. Şti. Message Board

jpnmqrtn 76 posts  |  Last Activity: Jul 7, 2016 5:36 PM Member since: Dec 7, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    here is something to ponder

    by atrs_00 Jul 7, 2016 4:37 PM
    jpnmqrtn jpnmqrtn Jul 7, 2016 5:36 PM Flag

    start clean you mean like find new investors; change the name, try a couple pumps? I imagine that would work well for these clowns. Are they going to do deal and refuel the aircraft or are they going to fly it into the delisting storm with the fuel gauge headed to zero. How big are the idiots we got running the show here?

    Shareholders gave them their Grade F

  • jpnmqrtn by jpnmqrtn Jun 28, 2016 9:39 AM Flag

    Journal of Oncology that would seem like a shorts worry?

    Did not they say atleast 3 times there is a story coming on VDA on Friday this week.

  • Reply to

    Futures Down 500 Points...

    by a1stocker Jun 23, 2016 10:41 PM
    jpnmqrtn jpnmqrtn Jun 26, 2016 8:11 AM Flag

    Mano, I think a further affiliation with GOG would be interesting.

    I believe that may be in the cards with Dr. Monk being present.
    It also gives Roche the ability to support the trial via Avastin through a charitable gift/ tax deductible charitable gift.

    Makes sense and that's why its too early to partner because there are financial benefits to staying divorced at the moment.

    Some notes were posted here a few months back about the loss carry forwards to BP on an eventual buyout.

    That is important and the tax implications are substantial.

    Can anyone on the MB summarize this angle with facts?

    Also, a question for the MB, does the FDA take into its account in approving a trial a reasonable review of finances?

    I am a little surprised the FDA appears 100 percent on board the MATN launch ship with questionable fuel levels to arrive at the end destination.

    I would have thought the FDA would have asked for a financial plan on how to get to the end? Not asked for it, but required it.

    How do patients know that this company has enough to get them all through their treatments?

    Enrolling in something partially funded seems a bit unlike the FDA.

  • Reply to

    AURELIA additional study results

    by pharma_cliff Jun 24, 2016 3:48 PM
    jpnmqrtn jpnmqrtn Jun 25, 2016 4:52 AM Flag

    Shorts 1.1 million and on the upswing. Let's hope something sparks them to cover.

  • Reply to

    Futures Down 500 Points...

    by a1stocker Jun 23, 2016 10:41 PM
    jpnmqrtn jpnmqrtn Jun 24, 2016 7:44 PM Flag

    Sandman talks the truth I believe what he says. I knew it was Russell rebalancing but didn't think about the micro cap funds. I have seen this quirk before.

    Hope your right on Monday we get a nugget.

    It is all about financing at this point. No one will board the rocket to da moon until they know there is fuel enough to get us there and back. Scweity got the countdown started for launch an Loar says we got enough to get us in orbit. Scweity says all aboard......needless to say no one boarding......let's hope Monday explains the refueling plan.

  • Reply to

    AURELIA additional study results

    by pharma_cliff Jun 24, 2016 3:48 PM
    jpnmqrtn jpnmqrtn Jun 24, 2016 7:14 PM Flag

    They probably knew the funds needed to liquidate and took advantage. The problem is there is no random buying here...none. All the Buying .is 0001 above the price fixers bid. No one buying the ask. Pretty easy to walk it down and sit on it. Not sure that makes any money just sitting around but the six month clock is ticking.

    Wait and see for now.

    Not sure if I were them, I would have posted my picture for all to see unless I had a little something to change the tone. As we saw from the vote, something bad happens to one of them we got six to eight million suspects. Just saying...

  • Reply to

    Futures Down 500 Points...

    by a1stocker Jun 23, 2016 10:41 PM
    jpnmqrtn jpnmqrtn Jun 24, 2016 6:55 PM Flag

    The price during that timeframe was generally a lot higher. So those short shares are significantly in the money. The top short count was 1.6 million at the very top in the past year. Shorting this at 90 cents is much different than 60 cents. Not saying they won't but the exposure to them rises. Although, as I said, it seems they are in the board room knowing exactly what happens next.

    Anyhow, I too think the OS data is significant enough to have added value to the IP. Although at this point, we got zero value. I am surprised the funds waited until the last minute of the last day to rebalance as described. The stock has been under $1 for a very long time.m they could have gotten a much better price then to have dumped them like they did.

  • Reply to

    Futures Down 500 Points...

    by a1stocker Jun 23, 2016 10:41 PM
    jpnmqrtn jpnmqrtn Jun 24, 2016 4:55 PM Flag

    This is not even close to qualifying as a Russell anything stock? Big short playing their games nothing more.

    I suspect we are getting ready for a rough ride again. Short count up to 1.1 million. Someone knows we got nothing but hot air coming on Monday. No way they pile in unless they know Monday has nothing material.

    I wait to be proven wrong but the "shorts" always know before a big move cause someone tells them.

    They will use the nothing new event on Monday against us.

  • Reply to

    2018-2019

    by pharma_cliff Jun 22, 2016 3:01 PM
    jpnmqrtn jpnmqrtn Jun 23, 2016 5:15 AM Flag

    Everyone here who throws out verified factual data confirmed by DD is FOS if it contrasts your rigid view point.
    The same thing is being said over/over and over. Shareholders, cancer patients, drug development science are all being held captive by inept over paid lying greedy management. Everyone in the circle of life loses except the people calling the shots. We just told them this in a very clear VOTE. We are waiting to see. Did they hear our opinion or not? Quite Frankly, giving their track record, I have some doubts. That simple.

  • Reply to

    2018-2019

    by pharma_cliff Jun 22, 2016 3:01 PM
    jpnmqrtn jpnmqrtn Jun 22, 2016 9:38 PM Flag

    And, I am still waiting, just bought at 72 in AH.

    I have waited a very long time here. So far nothing.

    If you want to help me feel better about this bunch explain question 2 and how they proposed their options awards in early 2017 would not face reverse split? They would have giving themselves 2.5 million shares each for reverse splitting us. Of course, they lost on question 2 with a blow out no vote. That was what they were proposing. If you agree giving the situation here that was a credible thing to do..just say so. I certainly do not. It points directly at the nature and thought process of thievery going on here.

    Help me understand the trust, credibility, shareholder interests in this stunt?

    Scweity files 525,000 share warrant allotment with SEC OOPS I only get 500,000 per plan limits.
    By my calculation and the number of days he was CEO he overpaid himself his max bonus amount.
    This is theft.
    All of the maximum awards are intended for outstanding results. We had no results and got trounced.
    It didn't matter max payout for everyone in every position.
    That's not the intent for variable payout incentives. It's suppose to be for getting results.

    I am hoping we over indulged last year knowing the end was just around the corner.

    But, here we are almost July, not much new.

  • Reply to

    2018-2019

    by pharma_cliff Jun 22, 2016 3:01 PM
    jpnmqrtn jpnmqrtn Jun 22, 2016 9:11 PM Flag

    A shareholder meeting in a South Korean owned hotel in NYC at 12 noon sharp. DR Monk stepping out for lunch? This certainly has looked like a retail stiff job from start to finish. I mean what IR team doesn't even talk to shareholders holding 100,000 to 300,000 shares? Then they have investor conferences with fake applause and talk about their pedigree. When was the last time they took a public question with a public audience? There is a very good reason for no more CC

  • Reply to

    2018-2019

    by pharma_cliff Jun 22, 2016 3:01 PM
    jpnmqrtn jpnmqrtn Jun 22, 2016 9:00 PM Flag

    I am with Mano on this one. This management team and BOD have displayed and incredible lack of physical ability to move the pipeline forward. Outsiders, whether it be GOG or Christie or whoever have done repeatedly all the heavy lifting. The capital raises when you think about it bought us what? Payment to the stooges was by far the biggest expense. What else got done? GNet/PNet? A very little internal expense on 4503.

    OS results, well what do you know a vascular disrupting agent works better on larger tumor than a smaller one.

    A VDA principle of action is to disrupt blood flow to the center of a tumor and starve the blood flow creating necrosis to the core of the tumor. So giving this thesis, ask 20 5th graders whether they think this drug would work better on large tumor or a small tumor.

    It's so so stupid it's just dumb. Yes, I like the fact this has confirmed itself and yes the numbers are good but how much more time are we going to lose with these idiots. This should have gone down the combo mode a long long long time ago and then worked its way back towards dual or mono therapies. They were trying to hit a home run blind folded and they weren't even hitting singles yet.

    It's sickening to watch. Scweity was on the BOD and as CEO has directly made the decisions to have no CC change the name, allow horrible structured annual meeting questions. Just horrible so far on the shareholder relation front. Pedigree so far a lying cheat.

    I think his overall strategy has been reasonable as CEO. Zero explanation of why we dropped the SPA and jumped in bed with Chemo. We were told multiple shots on goal and then that was retracted 100 days later.
    Lie

    I have been interested in any further Votrient trial info? Clinical trial on gov website says recruiting? Look at the new website presentation doesn't say anything? It would be nice to confirm action with someone else besides Avastin. Disappeared off the Radar screen...POOF. Intriguing remember. Lie

  • jpnmqrtn by jpnmqrtn Jun 12, 2016 9:54 AM Flag

    Web site says moving into P2 Early 2016.

    What does early 2016 mean?

    Intriguing or did this get shelved?

    Just a little guidance Scweity, we know doing your job is difficult for you.

    Ok I be a little more patient but come July 1 the definition of "early 2016" qualifies as another Scweity Lie.

    Intriguing already got downgraded to interesting. Elfloppo next in line? How would we possibly know with these all over the map scatter shots.

    Scweity get your act together. Even if it is an "act" so far you look an idiot.

    Truth be the truth

  • Reply to

    jpn

    by cpatrader2001 Jun 10, 2016 9:27 PM
    jpnmqrtn jpnmqrtn Jun 11, 2016 8:24 AM Flag

    Yes being long I appreciate Cliffs encouragement.

    Frankly though, I am mad as heck with the blatant management blunders. Look at the questions at the AGM. Look at the voting outcome. Look at 30 months no forward progress with main CA4P candidate. Scweity can not even file his options correctly with the SEC. I did some quick math on his pay and his start date as CEO and they over paid his 50 percent bonus as well. Overpaid by my account $5000 or so.

    Not by a big amount, but over paid on purpose, is THEFT. Why would they even consider the stunt?

    Why would he file 525,000 options when the plan limit is 500,000.
    They are making a point. These things are why no CC call ever again.

    Howson left zero explanation; Driscoll picks up a new gig, Pedder to the board right now with max options.

    The AGM questions were they designed to fail? Was the letter to shareholders just their way of saying, hey , we still got nothing, let you know someday down the road. We feel your pain when we deposit our pay checks!!!

    Any hoot sorry for the rant, for your questions.

    The cash burn and spend, no I don't think we are capitalized to get to the 80 readout.

    All the talk about the Avastin patent issues are something I too have been watching. It almost seems we have been stalling to line up with that expiration. With a convenient, last minute, tie up with Chemo. I don't think we are coming to these conclusions by looking over age old data. Someone is guiding this ship through to this end.

    Root was right about Chemo/Avastin SOC may have hurt our game plan.

    The cash situation brings real pressure to get a deal done.

    It seems to early to sell, but this is not a development company, I would not let these clowns near my data.
    So I think it is a deal that sells something.

    I still clearly see share grabbing going on here. Every time the volume drops to nil we get a new trigger.

    I will say we undoubtedly will be the last to know.

    Sandman you still with us? thought

  • jpnmqrtn jpnmqrtn Jun 10, 2016 8:25 PM Flag

    CPA,

    Who was cliffs telling to #$%$....

    I look up the ticker ?

    #$%$ must have gotten delisted.

    I hope he is right about the IP.

    Unfortunately, the lousy management is trumping the IP.

    It is amazing how we have traveled thes goat paths to no where and no one even suggests work hard and get the share price above a buck for 10 days.

    That's a novel idea; instead of a reverse split DYFJ.

    Check out that ticker....strong buy.

  • jpnmqrtn jpnmqrtn Jun 10, 2016 7:39 PM Flag

    Sounded like you unleashed all your shares today? Waiting to Buy back or are you done here? My cost average has been lowered dramatically by doing the same. Of course run the risk of being lightly loaded. I am moderately loaded and in the black for one day, yeah. I seriously don't know what to think about management who loses almost all the questions at the AGM and board members with lousy vote totals.

    I have never seen such a thing; in anything I ever owned. No, their lawyers will never let them take public questions under these circumstances. The AGM vote made it almost certain CC are not going to happen.

    Are you kidding? they were advocating direct theft from shareholders. No way their lawyers let them take incriminating questions regarding any of this.

  • jpnmqrtn jpnmqrtn Jun 10, 2016 5:07 PM Flag

    Votrient expansion P2 news was due early 2016; early would be Q1 June not exactly early. But, Soitenly by year end wasn't even close. Calculating the Scweity factor makes early 2016 ? October? Never?

    Nice not having CC eliminates all accountability, they don't have to state any goals, timelines, expectations, therefore, they can never miss a single objective...they don't have any.

  • Reply to

    Great News for OXGN!!!

    by rootbound43 Jun 10, 2016 10:41 AM
    jpnmqrtn jpnmqrtn Jun 10, 2016 11:16 AM Flag

    You never can tell for sure but the wagon looks like she is getting pretty full.

    When will they send her to the moon?

    Or will they implode her in place?

    I say to da moon my friends!

  • Reply to

    I love the smell of ........

    by vassego2005 Jun 10, 2016 8:35 AM
    jpnmqrtn jpnmqrtn Jun 10, 2016 8:48 AM Flag

    I think they are baiting them to re-short; see what happens..
    I expect a big filing on ownership soon...

  • Reply to

    News another share grab

    by jpnmqrtn Jun 10, 2016 7:50 AM
    jpnmqrtn jpnmqrtn Jun 10, 2016 8:21 AM Flag

    Another orphan drug designation. Gilioma